Portfolio Holdings Detail for ISIN IE00BF4RFH31
Stock Name / FundiShares MSCI World Small Cap UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300PZLRJB7M8H1057
ETF TickerWSML(USD) LSE
ETF TickerWLDS(GBP) LSE
ETF TickerIUSN(EUR) F
ETF TickerIUSN.DE(EUR) CXE
ETF TickerWLDS.LS(GBP) CXE
ETF TickerWSML.LS(USD) CXE
ETF TickerWSML.L(GBP) LSE
ETF TickerWLDS.L(GBP) LSE

Holdings detail for RNA

Stock NameAvidity Biosciences Inc
TickerRNA(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS05370A1088

Show aggregate RNA holdings

News associated with RNA

Avidity Biosciences, Inc. (NASDAQ:RNA) Shares Purchased by Hsbc Holdings PLC
Hsbc Holdings PLC lifted its holdings in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 111.4% in the 4th quarter, Holdings Channel.com reports. The fund owned 17,519 shares of the biotechnology company’s stock after buying an additional 9,230 shares during the quarter. Hsbc Holdings PLC’s holdings in Avidity Biosciences were worth $507,000 at the end […] - 2025-05-07 08:00:55
First Trust Advisors LP Buys 45,254 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
First Trust Advisors LP lifted its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 110.0% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 86,395 shares of the biotechnology company’s stock after acquiring an additional 45,254 shares during the period. First Trust Advisors LP […] - 2025-05-05 08:08:59
Envestnet Asset Management Inc. Sells 3,931 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
Envestnet Asset Management Inc. decreased its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 10.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 33,132 shares of the biotechnology company’s stock after selling 3,931 shares during the quarter. Envestnet […] - 2025-05-02 07:24:46
Raymond James Financial Inc. Makes New $5.78 Million Investment in Avidity Biosciences, Inc. (NASDAQ:RNA)
Raymond James Financial Inc. purchased a new stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 198,907 shares of the biotechnology company’s stock, valued at approximately $5,784,000. Other hedge funds and […] - 2025-04-25 09:43:06
Legal & General Group Plc Has $2.97 Million Stake in Avidity Biosciences, Inc. (NASDAQ:RNA)
Legal & General Group Plc lifted its position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 7.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 102,100 shares of the biotechnology company’s stock after purchasing an additional 6,937 shares […] - 2025-04-24 08:06:51
Summit Investment Advisors Inc. Buys 666 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
Summit Investment Advisors Inc. raised its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 6.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,611 shares of the biotechnology company’s stock after purchasing an additional 666 shares during the period. […] - 2025-04-21 07:56:51
Renaissance Technologies LLC Acquires 69,300 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
Renaissance Technologies LLC lifted its holdings in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 48.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 211,200 shares of the biotechnology company’s stock after acquiring an additional 69,300 shares during the period. Renaissance […] - 2025-04-20 08:00:56
Alliancebernstein L.P. Decreases Position in Avidity Biosciences, Inc. (NASDAQ:RNA)
Alliancebernstein L.P. decreased its holdings in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 25.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 127,770 shares of the biotechnology company’s stock after selling 42,914 shares during the quarter. Alliancebernstein L.P.’s holdings in Avidity […] - 2025-04-15 07:50:50
Avidity Biosciences, Inc. (NASDAQ:RNA) Shares Sold by JPMorgan Chase & Co.
JPMorgan Chase & Co. reduced its position in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 3.6% in the 4th quarter, Holdings Channel reports. The firm owned 450,144 shares of the biotechnology company’s stock after selling 16,941 shares during the period. JPMorgan Chase & Co.’s holdings in Avidity Biosciences were worth $13,090,000 as of its […] - 2025-04-14 08:13:06
Needham & Company LLC Reaffirms “Buy” Rating for Avidity Biosciences (NASDAQ:RNA)
Avidity Biosciences (NASDAQ:RNA – Get Free Report)‘s stock had its “buy” rating restated by Needham & Company LLC in a report released on Wednesday,Benzinga reports. They currently have a $60.00 target price on the biotechnology company’s stock. Needham & Company LLC’s target price would indicate a potential upside of 148.86% from the stock’s current price. […] - 2025-04-11 09:22:53
Sei Investments Co. Sells 19,149 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
Sei Investments Co. lessened its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 47.0% during the 4th quarter, HoldingsChannel.com reports. The fund owned 21,554 shares of the biotechnology company’s stock after selling 19,149 shares during the period. Sei Investments Co.’s holdings in Avidity Biosciences were worth $627,000 as of its most […] - 2025-04-09 07:28:50
Avidity Biosciences, Inc. (NASDAQ:RNA) Shares Purchased by Schroder Investment Management Group
Schroder Investment Management Group boosted its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 99.7% in the fourth quarter, Holdings Channel reports. The fund owned 61,480 shares of the biotechnology company’s stock after purchasing an additional 30,697 shares during the period. Schroder Investment Management Group’s holdings in Avidity Biosciences were worth […] - 2025-04-07 08:46:59
Mitsubishi UFJ Asset Management Co. Ltd. Has $171,000 Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA)
Mitsubishi UFJ Asset Management Co. Ltd. decreased its stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 36.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,621 shares of the biotechnology company’s stock after selling 3,292 shares during […] - 2025-04-04 08:55:03
KLP Kapitalforvaltning AS Acquires New Position in Avidity Biosciences, Inc. (NASDAQ:RNA)
KLP Kapitalforvaltning AS purchased a new position in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 17,900 shares of the biotechnology company’s stock, valued at approximately $521,000. Other institutional investors and hedge funds […] - 2025-04-04 07:46:49
Avidity Biosciences, Inc. (NASDAQ:RNA) Shares Sold by Corient Private Wealth LLC
Corient Private Wealth LLC lowered its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 6.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,525 shares of the biotechnology company’s stock after selling 731 shares during the quarter. […] - 2025-04-01 07:32:50
Cibc World Markets Corp Acquires New Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA)
Cibc World Markets Corp bought a new stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 10,386 shares of the biotechnology company’s stock, valued at approximately $302,000. A number of other […] - 2025-03-25 08:48:52
Raymond James Financial Inc. Acquires Shares of 198,907 Avidity Biosciences, Inc. (NASDAQ:RNA)
Raymond James Financial Inc. bought a new stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 198,907 shares of the biotechnology company’s stock, valued at approximately $5,784,000. Other hedge funds have also recently made changes to their positions in the company. Victory Capital Management Inc. […] - 2025-03-25 08:08:48
Avidity Biosciences, Inc. (NASDAQ:RNA) Receives $66.69 Average Target Price from Analysts
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has received a consensus rating of “Buy” from the thirteen research firms that are covering the company, MarketBeat.com reports. Thirteen analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokers that have covered the stock in the last year is […] - 2025-03-21 05:20:54
Chardan Capital Reaffirms Buy Rating for Avidity Biosciences (NASDAQ:RNA)
Chardan Capital reissued their buy rating on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a research note published on Monday,Benzinga reports. The firm currently has a $65.00 price target on the biotechnology company’s stock. Other analysts have also recently issued research reports about the company. Scotiabank began coverage on Avidity Biosciences in a […] - 2025-03-18 05:54:46
Avidity Biosciences (NASDAQ:RNA) Earns Sector Outperform Rating from Analysts at Scotiabank
Scotiabank began coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a report issued on Friday morning, MarketBeat Ratings reports. The brokerage issued a sector outperform rating and a $70.00 target price on the biotechnology company’s stock. Other analysts also recently issued research reports about the company. Chardan Capital reaffirmed a “buy” rating […] - 2025-03-10 05:50:51
Avidity Biosciences (NASDAQ:RNA) Shares Gap Down After Analyst Downgrade
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report)’s stock price gapped down before the market opened on Monday after Barclays lowered their price target on the stock from $63.00 to $57.00. The stock had previously closed at $30.64, but opened at $29.90. Barclays currently has an overweight rating on the stock. Avidity Biosciences shares last […] - 2025-03-04 06:37:23
Barclays Cuts Avidity Biosciences (NASDAQ:RNA) Price Target to $57.00
Avidity Biosciences (NASDAQ:RNA – Free Report) had its target price cut by Barclays from $63.00 to $57.00 in a research report sent to investors on Friday morning,Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. Other equities research analysts also recently issued reports about the stock. Needham & Company LLC reissued […] - 2025-03-03 06:48:54
New York State Common Retirement Fund Buys 598 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
New York State Common Retirement Fund raised its stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 0.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 184,811 shares of the biotechnology company’s stock after acquiring an additional 598 shares during the period. […] - 2025-02-28 09:04:58
Avidity Biosciences, Inc. (NASDAQ:RNA) Shares Bought by State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D lifted its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 8.1% during the fourth quarter, Holdings Channel reports. The firm owned 48,536 shares of the biotechnology company’s stock after buying an additional 3,638 shares during the period. State of New Jersey Common Pension […] - 2025-02-26 08:31:05
Analysts Set Avidity Biosciences, Inc. (NASDAQ:RNA) PT at $65.80
Shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) have earned a consensus recommendation of “Buy” from the ten ratings firms that are currently covering the stock, Marketbeat.com reports. Ten analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokerages that have covered the stock in the last […] - 2025-02-24 06:30:54
abrdn plc Buys 20,076 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
abrdn plc raised its stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 80.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 44,912 shares of the biotechnology company’s stock after purchasing an additional 20,076 shares during the period. abrdn plc’s holdings in […] - 2025-02-11 08:24:48

iShares MSCI World Small Cap UCITS ETF USD (Acc) RNA holdings

DateNumber of RNA Shares HeldBase Market Value of RNA SharesLocal Market Value of RNA SharesChange in RNA Shares HeldChange in RNA Base ValueCurrent Price per RNA Share HeldPrevious Price per RNA Share Held
2025-05-08 (Thursday)54,826USD 1,572,958USD 1,572,958
2025-05-07 (Wednesday)54,826USD 1,434,796USD 1,434,796
2025-05-06 (Tuesday)54,460USD 1,430,120RNA holding decreased by -327849USD 1,430,1200USD -327,849 USD 26.26 USD 32.28
2025-05-05 (Monday)54,460USD 1,757,969RNA holding increased by 4357USD 1,757,9690USD 4,357 USD 32.28 USD 32.2
2025-05-02 (Friday)54,460USD 1,753,612RNA holding decreased by -26685USD 1,753,6120USD -26,685 USD 32.2 USD 32.69
2025-05-01 (Thursday)54,460USD 1,780,297RNA holding increased by 2178USD 1,780,2970USD 2,178 USD 32.69 USD 32.65
2025-04-30 (Wednesday)54,460USD 1,778,119RNA holding increased by 26685USD 1,778,1190USD 26,685 USD 32.65 USD 32.16
2025-04-29 (Tuesday)54,460USD 1,751,434RNA holding increased by 52010USD 1,751,4340USD 52,010 USD 32.16 USD 31.205
2025-04-28 (Monday)54,460RNA holding increased by 122USD 1,699,424RNA holding increased by 23640USD 1,699,424122USD 23,640 USD 31.205 USD 30.84
2025-04-25 (Friday)54,338USD 1,675,784RNA holding decreased by -4890USD 1,675,7840USD -4,890 USD 30.84 USD 30.93
2025-04-24 (Thursday)54,338USD 1,680,674RNA holding increased by 13584USD 1,680,6740USD 13,584 USD 30.93 USD 30.68
2025-04-23 (Wednesday)54,338USD 1,667,090RNA holding increased by 66836USD 1,667,0900USD 66,836 USD 30.68 USD 29.45
2025-04-22 (Tuesday)54,338USD 1,600,254RNA holding increased by 50534USD 1,600,2540USD 50,534 USD 29.45 USD 28.52
2025-04-21 (Monday)54,338USD 1,549,720RNA holding increased by 101069USD 1,549,7200USD 101,069 USD 28.52 USD 26.66
2025-04-18 (Friday)54,338USD 1,448,651USD 1,448,6510USD 0 USD 26.66 USD 26.66
2025-04-17 (Thursday)54,338USD 1,448,651RNA holding increased by 48904USD 1,448,6510USD 48,904 USD 26.66 USD 25.76
2025-04-16 (Wednesday)54,338RNA holding increased by 1599USD 1,399,747RNA holding decreased by -7330USD 1,399,7471,599USD -7,330 USD 25.76 USD 26.68
2025-04-15 (Tuesday)52,739USD 1,407,077RNA holding decreased by -12129USD 1,407,0770USD -12,129 USD 26.68 USD 26.91
2025-04-14 (Monday)52,739RNA holding increased by 246USD 1,419,206RNA holding increased by 76435USD 1,419,206246USD 76,435 USD 26.91 USD 25.58
2025-04-11 (Friday)52,493USD 1,342,771RNA holding increased by 77165USD 1,342,7710USD 77,165 USD 25.58 USD 24.11
2025-04-10 (Thursday)52,493USD 1,265,606RNA holding decreased by -36220USD 1,265,6060USD -36,220 USD 24.11 USD 24.8
2025-04-09 (Wednesday)52,493USD 1,301,826RNA holding increased by 37795USD 1,301,8260USD 37,795 USD 24.8 USD 24.08
2025-04-08 (Tuesday)52,493RNA holding decreased by -246USD 1,264,031RNA holding decreased by -79759USD 1,264,031-246USD -79,759 USD 24.08 USD 25.48
2025-04-07 (Monday)52,739USD 1,343,790RNA holding decreased by -57485USD 1,343,7900USD -57,485 USD 25.48 USD 26.57
2025-04-04 (Friday)52,739RNA holding decreased by -246USD 1,401,275RNA holding decreased by -176088USD 1,401,275-246USD -176,088 USD 26.57 USD 29.77
2025-04-02 (Wednesday)52,985USD 1,577,363RNA holding increased by 160544USD 1,577,3630USD 160,544 USD 29.77 USD 26.74
2025-04-01 (Tuesday)52,985USD 1,416,819RNA holding decreased by -147298USD 1,416,8190USD -147,298 USD 26.74 USD 29.52
2025-03-31 (Monday)52,985USD 1,564,117RNA holding decreased by -110209USD 1,564,1170USD -110,209 USD 29.52 USD 31.6
2025-03-28 (Friday)52,985RNA holding increased by 1220USD 1,674,326RNA holding decreased by -11142USD 1,674,3261,220USD -11,142 USD 31.6 USD 32.56
2025-03-27 (Thursday)51,765USD 1,685,468RNA holding increased by 26400USD 1,685,4680USD 26,400 USD 32.56 USD 32.05
2025-03-26 (Wednesday)51,765USD 1,659,068RNA holding decreased by -2589USD 1,659,0680USD -2,589 USD 32.05 USD 32.1
2025-03-25 (Tuesday)51,765USD 1,661,657RNA holding decreased by -62118USD 1,661,6570USD -62,118 USD 32.1 USD 33.3
2025-03-24 (Monday)51,765USD 1,723,775RNA holding increased by 127342USD 1,723,7750USD 127,342 USD 33.3 USD 30.84
2025-03-21 (Friday)51,765USD 1,596,433RNA holding increased by 518USD 1,596,4330USD 518 USD 30.84 USD 30.83
2025-03-20 (Thursday)51,765USD 1,595,915RNA holding decreased by -46071USD 1,595,9150USD -46,071 USD 30.83 USD 31.72
2025-03-19 (Wednesday)51,765USD 1,641,986RNA holding increased by 64189USD 1,641,9860USD 64,189 USD 31.72 USD 30.48
2025-03-18 (Tuesday)51,765USD 1,577,797RNA holding decreased by -173413USD 1,577,7970USD -173,413 USD 30.48 USD 33.83
2025-03-17 (Monday)51,765USD 1,751,210RNA holding increased by 140801USD 1,751,2100USD 140,801 USD 33.83 USD 31.11
2025-03-14 (Friday)51,765USD 1,610,409RNA holding decreased by -52800USD 1,610,4090USD -52,800 USD 31.11 USD 32.13
2025-03-13 (Thursday)51,765USD 1,663,209RNA holding decreased by -24848USD 1,663,2090USD -24,848 USD 32.13 USD 32.61
2025-03-12 (Wednesday)51,765RNA holding decreased by -246USD 1,688,057RNA holding increased by 149572USD 1,688,057-246USD 149,572 USD 32.61 USD 29.58
2025-03-11 (Tuesday)52,011USD 1,538,485RNA holding decreased by -23925USD 1,538,4850USD -23,925 USD 29.58 USD 30.04
2025-03-10 (Monday)52,011USD 1,562,410RNA holding decreased by -13003USD 1,562,4100USD -13,003 USD 30.04 USD 30.29
2025-03-07 (Friday)52,011USD 1,575,413RNA holding increased by 38488USD 1,575,4130USD 38,488 USD 30.29 USD 29.55
2025-03-05 (Wednesday)52,011USD 1,536,925RNA holding increased by 51491USD 1,536,9250USD 51,491 USD 29.55 USD 28.56
2025-03-04 (Tuesday)52,011RNA holding decreased by -246USD 1,485,434RNA holding decreased by -41516USD 1,485,434-246USD -41,516 USD 28.56 USD 29.22
2025-03-03 (Monday)52,257USD 1,526,950RNA holding decreased by -74204USD 1,526,9500USD -74,204 USD 29.22 USD 30.64
2025-02-28 (Friday)52,257RNA holding decreased by -7244USD 1,601,154RNA holding decreased by -129135USD 1,601,154-7,244USD -129,135 USD 30.64 USD 29.08
2025-02-27 (Thursday)59,501USD 1,730,289RNA holding decreased by -33916USD 1,730,2890USD -33,916 USD 29.08 USD 29.65
2025-02-26 (Wednesday)59,501RNA holding decreased by -556USD 1,764,205RNA holding increased by 12943USD 1,764,205-556USD 12,943 USD 29.65 USD 29.16
2025-02-25 (Tuesday)60,057USD 1,751,262RNA holding decreased by -82278USD 1,751,2620USD -82,278 USD 29.16 USD 30.53
2025-02-24 (Monday)60,057USD 1,833,540RNA holding decreased by -35434USD 1,833,5400USD -35,434 USD 30.53 USD 31.12
2025-02-21 (Friday)60,057USD 1,868,974RNA holding decreased by -84680USD 1,868,9740USD -84,680 USD 31.12 USD 32.53
2025-02-20 (Thursday)60,057USD 1,953,654RNA holding increased by 37836USD 1,953,6540USD 37,836 USD 32.53 USD 31.9
2025-02-19 (Wednesday)60,057USD 1,915,818RNA holding decreased by -6006USD 1,915,8180USD -6,006 USD 31.9 USD 32
2025-02-18 (Tuesday)60,057USD 1,921,824RNA holding decreased by -18618USD 1,921,8240USD -18,618 USD 32 USD 32.31
2025-02-17 (Monday)60,057USD 1,940,442USD 1,940,4420USD 0 USD 32.31 USD 32.31
2025-02-14 (Friday)60,057USD 1,940,442RNA holding decreased by -42640USD 1,940,4420USD -42,640 USD 32.31 USD 33.02
2025-02-13 (Thursday)60,057RNA holding increased by 140USD 1,983,082RNA holding increased by 75924USD 1,983,082140USD 75,924 USD 33.02 USD 31.83
2025-02-12 (Wednesday)59,917RNA holding increased by 556USD 1,907,158RNA holding decreased by -98650USD 1,907,158556USD -98,650 USD 31.83 USD 33.79
2025-02-11 (Tuesday)59,361USD 2,005,808RNA holding decreased by -30868USD 2,005,8080USD -30,868 USD 33.79 USD 34.31
2025-02-10 (Monday)59,361USD 2,036,676RNA holding decreased by -36210USD 2,036,6760USD -36,210 USD 34.31 USD 34.92
2025-02-07 (Friday)59,361USD 2,072,886RNA holding decreased by -11279USD 2,072,8860USD -11,279 USD 34.92 USD 35.11
2025-02-06 (Thursday)59,361USD 2,084,165RNA holding increased by 25526USD 2,084,1650USD 25,526 USD 35.11 USD 34.68
2025-02-05 (Wednesday)59,361USD 2,058,639RNA holding increased by 79543USD 2,058,6390USD 79,543 USD 34.68 USD 33.34
2025-02-04 (Tuesday)59,361USD 1,979,096RNA holding increased by 81918USD 1,979,0960USD 81,918 USD 33.34 USD 31.96
2025-02-03 (Monday)59,361USD 1,897,178RNA holding decreased by -57580USD 1,897,1780USD -57,580 USD 31.96 USD 32.93
2025-01-31 (Friday)59,361USD 1,954,758RNA holding increased by 17809USD 1,954,7580USD 17,809 USD 32.93 USD 32.63
2025-01-30 (Thursday)59,361USD 1,936,949RNA holding increased by 42146USD 1,936,9490USD 42,146 USD 32.63 USD 31.92
2025-01-29 (Wednesday)59,361USD 1,894,803RNA holding decreased by -9498USD 1,894,8030USD -9,498 USD 31.92 USD 32.08
2025-01-28 (Tuesday)59,361USD 1,904,301RNA holding increased by 97352USD 1,904,3010USD 97,352 USD 32.08 USD 30.44
2025-01-27 (Monday)59,361RNA holding increased by 139USD 1,806,949RNA holding increased by 49832USD 1,806,949139USD 49,832 USD 30.44 USD 29.67
2025-01-24 (Friday)59,222USD 1,757,117RNA holding decreased by -27242USD 1,757,1170USD -27,242 USD 29.67 USD 30.13
2025-01-23 (Thursday)59,222RNA holding increased by 139USD 1,784,359RNA holding increased by 7142USD 1,784,359139USD 7,142 USD 30.13 USD 30.08
2025-01-22 (Wednesday)59,083USD 1,777,217RNA holding decreased by -44903USD 1,777,2170USD -44,903 USD 30.08 USD 30.84
2025-01-22 (Wednesday)59,083USD 1,777,217RNA holding decreased by -44903USD 1,777,2170USD -44,903 USD 30.08 USD 30.84
2025-01-21 (Tuesday)59,083USD 1,822,120USD 1,822,120
2025-01-20 (Monday)59,083USD 1,708,680USD 1,708,680
2025-01-17 (Friday)59,083USD 1,708,680USD 1,708,680
2025-01-16 (Thursday)59,083USD 1,671,458USD 1,671,458
2025-01-15 (Wednesday)59,083USD 1,646,643USD 1,646,643
2025-01-14 (Tuesday)59,083USD 1,598,195USD 1,598,195
2025-01-13 (Monday)59,083USD 1,678,548USD 1,678,548
2025-01-10 (Friday)59,083USD 1,740,585USD 1,740,585
2025-01-09 (Thursday)59,083USD 1,768,354USD 1,768,354
2025-01-09 (Thursday)59,083USD 1,768,354USD 1,768,354
2025-01-09 (Thursday)59,083USD 1,768,354USD 1,768,354
2025-01-08 (Wednesday)59,083USD 1,768,354USD 1,768,354
2025-01-08 (Wednesday)59,083USD 1,768,354USD 1,768,354
2025-01-08 (Wednesday)59,083USD 1,768,354USD 1,768,354
2025-01-02 (Thursday)60,063USD 1,872,764USD 1,872,764
2024-12-30 (Monday)60,063USD 1,752,638USD 1,752,638
2024-12-18 (Wednesday)60,063USD 1,843,934USD 1,843,934
2024-12-10 (Tuesday)59,504USD 2,148,094RNA holding decreased by -44628USD 2,148,0940USD -44,628 USD 36.1 USD 36.85
2024-12-09 (Monday)59,504RNA holding increased by 5004USD 2,192,722RNA holding increased by 107007USD 2,192,7225,004USD 107,007 USD 36.85 USD 38.27
2024-12-06 (Friday)54,500USD 2,085,715RNA holding increased by 75755USD 2,085,7150USD 75,755 USD 38.27 USD 36.88
2024-12-05 (Thursday)54,500USD 2,009,960RNA holding decreased by -57225USD 2,009,9600USD -57,225 USD 36.88 USD 37.93
2024-12-04 (Wednesday)54,500RNA holding increased by 276USD 2,067,185RNA holding decreased by -19355USD 2,067,185276USD -19,355 USD 37.93 USD 38.48
2024-12-03 (Tuesday)54,224RNA holding increased by 414USD 2,086,540RNA holding decreased by -135813USD 2,086,540414USD -135,813 USD 38.48 USD 41.3
2024-12-02 (Monday)53,810USD 2,222,353RNA holding decreased by -93091USD 2,222,3530USD -93,091 USD 41.3 USD 43.03
2024-11-29 (Friday)53,810USD 2,315,444RNA holding decreased by -16143USD 2,315,4440USD -16,143 USD 43.03 USD 43.33
2024-11-28 (Thursday)53,810USD 2,331,587USD 2,331,5870USD 0 USD 43.33 USD 43.33
2024-11-27 (Wednesday)53,810USD 2,331,587RNA holding decreased by -25291USD 2,331,5870USD -25,291 USD 43.33 USD 43.8
2024-11-26 (Tuesday)53,810USD 2,356,878RNA holding decreased by -71567USD 2,356,8780USD -71,567 USD 43.8 USD 45.13
2024-11-25 (Monday)53,810RNA holding increased by 10276USD 2,428,445RNA holding increased by 545599USD 2,428,44510,276USD 545,599 USD 45.13 USD 43.25
2024-11-22 (Friday)43,534USD 1,882,846RNA holding increased by 30039USD 1,882,8460USD 30,039 USD 43.25 USD 42.56
2024-11-21 (Thursday)43,534USD 1,852,807RNA holding decreased by -47452USD 1,852,8070USD -47,452 USD 42.56 USD 43.65
2024-11-20 (Wednesday)43,534USD 1,900,259RNA holding increased by 17413USD 1,900,2590USD 17,413 USD 43.65 USD 43.25
2024-11-19 (Tuesday)43,534RNA holding increased by 678USD 1,882,846RNA holding increased by 110750USD 1,882,846678USD 110,750 USD 43.25 USD 41.35
2024-11-18 (Monday)42,856RNA holding increased by 224USD 1,772,096RNA holding decreased by -220097USD 1,772,096224USD -220,097 USD 41.35 USD 46.73
2024-11-12 (Tuesday)42,632RNA holding increased by 448USD 1,992,193RNA holding increased by 4483USD 1,992,193448USD 4,483 USD 46.73 USD 47.12
2024-11-11 (Monday)42,184RNA holding increased by 112USD 1,987,710RNA holding increased by 22106USD 1,987,710112USD 22,106 USD 47.12 USD 46.72
2024-11-08 (Friday)42,072USD 1,965,604RNA holding decreased by -33237USD 1,965,6040USD -33,237 USD 46.72 USD 47.51
2024-11-07 (Thursday)42,072RNA holding increased by 560USD 1,998,841RNA holding increased by 37814USD 1,998,841560USD 37,814 USD 47.51 USD 47.24
2024-11-06 (Wednesday)41,512USD 1,961,027RNA holding increased by 89251USD 1,961,0270USD 89,251 USD 47.24 USD 45.09
2024-11-05 (Tuesday)41,512USD 1,871,776RNA holding increased by 11208USD 1,871,7760USD 11,208 USD 45.09 USD 44.82
2024-11-04 (Monday)41,512USD 1,860,568RNA holding increased by 122461USD 1,860,5680USD 122,461 USD 44.82 USD 41.87
2024-11-01 (Friday)41,512USD 1,738,107RNA holding decreased by -16190USD 1,738,1070USD -16,190 USD 41.87 USD 42.26
2024-10-31 (Thursday)41,512USD 1,754,297RNA holding decreased by -39852USD 1,754,2970USD -39,852 USD 42.26 USD 43.22
2024-10-30 (Wednesday)41,512USD 1,794,149RNA holding decreased by -56041USD 1,794,1490USD -56,041 USD 43.22 USD 44.57
2024-10-29 (Tuesday)41,512USD 1,850,190RNA holding decreased by -47739USD 1,850,1900USD -47,739 USD 44.57 USD 45.72
2024-10-28 (Monday)41,512USD 1,897,929RNA holding increased by 25323USD 1,897,9290USD 25,323 USD 45.72 USD 45.11
2024-10-25 (Friday)41,512USD 1,872,606RNA holding decreased by -1661USD 1,872,6060USD -1,661 USD 45.11 USD 45.15
2024-10-24 (Thursday)41,512USD 1,874,267RNA holding decreased by -10378USD 1,874,2670USD -10,378 USD 45.15 USD 45.4
2024-10-23 (Wednesday)41,512RNA holding increased by 222USD 1,884,645RNA holding decreased by -71675USD 1,884,645222USD -71,675 USD 45.4 USD 47.38
2024-10-22 (Tuesday)41,290USD 1,956,320RNA holding increased by 27664USD 1,956,3200USD 27,664 USD 47.38 USD 46.71
2024-10-21 (Monday)41,290USD 1,928,656RNA holding decreased by -154425USD 1,928,6560USD -154,425 USD 46.71 USD 50.45
2024-10-18 (Friday)41,290USD 2,083,081USD 2,083,081
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RNA by Blackrock for IE00BF4RFH31

Show aggregate share trades of RNA

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-04-28BUY122 31.205* 34.73
2025-04-16BUY1,599 25.760* 35.25
2025-04-14BUY246 26.910* 35.43
2025-04-08SELL-246 24.080* 35.93 Profit of 8,838 on sale
2025-04-04SELL-246 26.570* 36.16 Profit of 8,896 on sale
2025-03-28BUY1,220 31.600* 36.49
2025-03-12SELL-246 32.610* 37.28 Profit of 9,172 on sale
2025-03-04SELL-246 28.560* 37.88 Profit of 9,319 on sale
2025-02-28SELL-7,244 30.640* 38.14 Profit of 276,279 on sale
2025-02-26SELL-556 29.650* 38.43 Profit of 21,368 on sale
2025-02-13BUY140 33.020* 39.63
2025-02-12BUY556 31.830* 39.78
2025-01-27BUY139 30.440* 41.87
2025-01-23BUY139 30.130* 42.54
2024-12-09BUY5,004 36.850* 43.69
2024-12-04BUY276 37.930* 44.31
2024-12-03BUY414 38.480* 44.52
2024-11-25BUY10,276 45.130* 44.85
2024-11-19BUY678 43.250* 45.22
2024-11-18BUY224 41.350* 45.45
2024-11-12BUY448 46.730* 45.37
2024-11-11BUY112 47.120* 45.25
2024-11-07BUY560 47.510* 44.96
2024-10-23BUY222 45.400* 47.04
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RNA

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-05-09397,09734464,77685.4%
2025-05-08761,4952341,082,33170.4%
2025-05-07369,0262,438761,08948.5%
2025-05-06907,88215,5391,622,97055.9%
2025-05-05179,49617279,28364.3%
2025-05-02408,668802589,35969.3%
2025-05-01310,460106352,25588.1%
2025-04-30227,85353329,07569.2%
2025-04-29215,636220298,47172.2%
2025-04-28183,870253265,80169.2%
2025-04-25223,6705,721359,71762.2%
2025-04-24233,079439509,60145.7%
2025-04-23393,822805485,61081.1%
2025-04-22542,024390881,75461.5%
2025-04-21399,3123,084553,97372.1%
2025-04-17299,969200780,33038.4%
2025-04-16290,460281398,63172.9%
2025-04-15203,633788431,61147.2%
2025-04-14208,090483391,04853.2%
2025-04-11319,8260435,22073.5%
2025-04-10299,2884,142598,75850.0%
2025-04-09535,49013,6021,557,58834.4%
2025-04-08569,28295861,34466.1%
2025-04-07432,834685816,52253.0%
2025-04-04507,72045799,82963.5%
2025-04-03664,6861541,011,47965.7%
2025-04-021,203,9036,2421,775,36667.8%
2025-04-01582,8282,4721,170,51149.8%
2025-03-311,090,8442681,592,24368.5%
2025-03-28233,043718272,76885.4%
2025-03-27460,852100524,23287.9%
2025-03-26487,1194,035541,42590.0%
2025-03-25328,4831,737410,01780.1%
2025-03-24370,2524,056403,38991.8%
2025-03-21200,226338248,23380.7%
2025-03-20363,7151,332629,76157.8%
2025-03-19187,68069362,61651.8%
2025-03-18415,9421,047557,40274.6%
2025-03-17384,71814,190557,38269.0%
2025-03-14434,2791,383549,31779.1%
2025-03-13471,2541,446747,05963.1%
2025-03-12356,1183,419533,69666.7%
2025-03-11246,772473349,12070.7%
2025-03-10206,439125294,19670.2%
2025-03-07227,754158326,61769.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.